Dexcom Inc., US2521311074

Dexcom stock heads into the open after a 3.8 percent drop

Published on 09/09/2026 at 04:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 8, 2026, Dexcom stock fell 3.8 percent to USD 84.53. The move left the shares 17.3 percent below the GF Value estimate and within their 52-week range of USD 54.11 to USD 92.59.

Fotorealistischer CGM-Sensor-Patch am Arm, klinisches Umfeld, Medizintechnik
Dexcom Inc. zeigt fotorealistischen CGM-Sensor am Unterarm für Anleger mit ISIN US2521311074 Medizintechnik, Illustration mit AI erstellt.

Dexcom stock closed at USD 84.53 on the Nasdaq on September 8, 2026, down 3.8 percent. The move left the shares 17.3 percent below GuruFocus' GF Value estimate of USD 102.23 and inside a 52-week range of USD 54.11 to USD 92.59.

September 8, 2026 in numbers

DexCom Inc. (ISIN US2521311074, Nasdaq: DXCM) fell after GuruFocus said the stock finished September 8, 2026 at USD 84.53. The same source put the share price 17.3 percent below its GF Value estimate and showed a year-to-date gain of 27.4 percent, while the 52-week low and high stood at USD 54.11 and USD 92.59.

MarketBeat reported that DexCom's latest quarterly results were released on July 30, 2026, with revenue of USD 1.31 billion and earnings of USD 0.70 a share, above the consensus estimate of USD 0.61. U.S. index futures and broader Wall Street trading also remained in view after the Nasdaq Composite closed lower in the prior session.

Today ahead of the open

DexCom is not due to release fresh results today. U.S. inflation data later this week can still shape growth-stock trading, and any move in the Nasdaq Composite may influence sentiment toward the shares.

Disclaimer...

en | US2521311074 | DEXCOM INC. | boerse | 70072100 | bgmi